united states of america 05 14 2014 - federal trade … · united states of america ... providyn...
TRANSCRIPT
UNITED STATES OF AMERICA BEFORE THE FEDERAL TRADE COMMISSION OFFICE OF ADMINISTRATIVE LAW JUDGES
____________________________________ ) In the Matter of ) PUBLIC ) LabMD, Inc., ) Docket No. 9357 a corporation, ) Respondent. ) ) ____________________________________)
JOINT STIPULATIONS ON ADMISSIBILITY OF EXHIBITS
1. The parties hereby stipulate and agree that the Joint Exhibits listed hereto in
Attachment A are admitted without objection.
2. The parties hereby stipulate and agree that all exhibits that are listed in each party’s
Exhibit List not appearing in Attachment A may be conditionally admitted to the record.
The parties reserve all objections previously asserted to these materials, including
objections to designated and counter-designated testimony in transcript exhibits.
Complaint Counsel has separately submitted its objections to Respondent’s designated
and counter-designated testimony. If such materials are relied upon in post-trial briefing
of findings of fact or conclusions of law, any party may re-assert an objection to such
material at that stage of the proceeding. The objection may be made in reply briefs or in
any appropriate form. If such material is used during the Hearing for any reason, a party
may elect to seek a ruling on an objection at that time or defer asserting the objection
until post-trial briefing and such objections are not waived if not asserted during the
Hearing. The parties further stipulate that any evidentiary material not identified in post-
JX0002 page 1
05 14 2014
JX0002 page 2
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#
RX1
CX0
687
6/1/
07 D
ay S
heet
Tra
nsac
tion
Det
ails
LabM
D IH
Ex.
7 -
Che
cks
and
LabM
D
Day
She
ets,
reda
cted
6/1/
2007
FTC
-000
169
FTC
-000
224
RX6
CX0
402
Sen
tinel
Net
wor
k C
ompl
aint
C
onsu
mer
Sen
tinel
Com
plai
nt b
y P
eter
C
uttin
oFT
C-0
0066
1FT
C-0
0067
5R
X7C
X044
1FT
C e
nvel
op s
can
Lette
r J. H
ayes
to R
. Yod
aike
n at
tach
ing
LabM
D B
reac
h N
otic
e Le
tter
4/10
/201
3FT
C-0
0068
0FT
C-0
0068
4R
X8C
X049
1Le
tter f
rom
Mik
e D
augh
erty
to
Pro
viD
yn, I
nc.
Pro
vidy
n A
utho
rizat
ion
to P
erfo
rm
Ext
erna
l Net
wor
k Te
stin
g5/
18/2
010
FTC
-PV
D-0
0000
1FT
C-P
VD
-000
001
RX9
CX0
047
Ser
vice
Sol
utio
ns P
ropo
sal f
or
LabM
D fr
om P
rovi
Dyn
, Inc
. P
rovi
dyn
Ser
vice
Sol
utio
ns P
ropo
sal f
or
LabM
D, u
nexe
cute
d20
10FT
C-P
VD
-000
015
FTC
-PV
D-0
0001
7R
X10
CX0
042
Em
ail f
rom
H. D
avid
son
to M
. D
augh
erty
dat
ed
5/18
/201
0FT
C-P
VD
-000
020
FTC
-PV
D-0
0002
2R
X11
CX0
042
Ser
vice
Sol
utio
ns P
ropo
sal f
or
LabM
D fr
om P
rovi
Dyn
, Inc
.7/
2/19
05FT
C-P
VD
-000
023
FTC
-PV
D-0
0002
6R
X12
CX0
042
Lette
r fro
m M
ike
Dau
gher
ty to
P
rovi
Dyn
, Inc
. 5/
18/2
010
FTC
-PV
D-0
0002
7FT
C-P
VD
-000
027
RX1
3C
X004
8In
voic
e to
Lab
MD
from
Pro
viD
yn,
Inc.
P
rovi
dyn
Invo
ice
2172
5/25
/201
0FT
C-P
VD
-000
038
FTC
-PV
D-0
0003
8R
X14
CX0
049
Invo
ice
to L
abM
D fr
om P
rovi
Dyn
, In
c.
Pro
vidy
n In
voic
e 22
367/
19/2
010
FTC
-PV
D-0
0003
9FT
C-P
VD
-000
039
RX1
5C
X005
0In
voic
e to
Lab
MD
from
Pro
viD
yn,
Inc.
P
rovi
dyn
Invo
ice
2300
9/6/
2010
FTC
-PV
D-0
0004
0FT
C-P
VD
-000
040
RX2
1C
X005
1S
ervi
ce S
olut
ions
Pro
posa
l for
La
bMD
from
Pro
viD
ynP
rovi
dyn
Ser
vice
Sol
utio
ns P
ropo
sal f
or
LabM
D, e
xecu
ted
by M
. Dau
gher
ty5/
28/2
010
FTC
-PV
D-0
0004
9FT
C-P
VD
-000
053
RX2
2C
X005
5Fu
ll R
epor
t Ana
lysi
s
Pro
vidy
n N
etw
ork
Sec
urity
Sca
n -
Dem
ogra
phic
s7/
18/2
010
FTC
-PV
D-0
0009
4FT
C-P
VD
-000
120
RX2
4C
X005
7Fu
ll R
epor
t Ana
lysi
s P
rovi
dyn
Net
wor
k S
ecur
ity S
can
- Fi
rew
all
9/3/
2010
FTC
-PV
D-0
0024
1FT
C-P
VD
-000
265
RX2
5C
X005
9Fu
ll R
epor
t Ana
lysi
s P
rovi
dyn
Net
wor
k S
ecur
ity S
can
- Mai
l9/
3/20
10FT
C-P
VD
-000
315
FTC
-PV
D-0
0038
7R
X26
CX0
061
Full
Rep
ort A
naly
sis
Pro
vidy
n N
etw
ork
Sec
urity
Sca
n -
Map
per
9/3/
2010
FTC
-PV
D-0
0041
6FT
C-P
VD
-000
442
RX2
7C
X006
2Fu
ll R
epor
t Ana
lysi
s P
rovi
dyn
Net
wor
k S
ecur
ity S
can
- D
emog
raph
ics
9/3/
2010
FTC
-PV
D-0
0044
3FT
C-P
VD
-000
466
Cat
egor
y 1:
Exh
ibits
App
earin
g on
bot
h R
espo
nden
t's a
nd C
ompl
aint
Cou
nsel
's E
xhib
it Li
sts
to w
hich
Nei
ther
Par
ty O
bjec
ts
CX0
042
(incl
udin
g al
l of R
X10-
12):
Em
ail H
. Dav
idso
n to
M. D
augh
erty
S
ubje
ct R
E: P
rovi
dyn
Follo
w U
p,
atta
chin
g La
bMD
Ext
erna
l Vul
nera
bilit
y S
can.
pdf a
nd A
uth.
To
Per
form
E
xter
nal N
etw
ork
Sca
n.do
c
FTC
Doc
ket N
o. 9
357
Pag
e 1
of 1
7JX
0002
pag
e 3
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#R
X28
CX0
063
Full
Rep
ort A
naly
sis
Pro
vidy
n N
etw
ork
Sec
urity
Sca
n -
Spe
cial
ty V
PN
9/3/
2010
FTC
-PV
D-0
0046
7FT
C-P
VD
-000
490
RX2
9C
X006
4Fu
ll R
epor
t Ana
lysi
s P
rovi
dyn
Net
wor
k S
ecur
ity S
can
- N
etw
ork
Prin
ter
9/3/
2010
FTC
-PV
D-0
0049
1FT
C-P
VD
-000
514
RX3
0C
X006
5Fu
ll R
epor
t Ana
lysi
s P
rovi
dyn
Net
wor
k S
ecur
ity S
can
- La
bCor
p V
PN
9/3/
2010
FTC
-PV
D-0
0051
5FT
C-P
VD
-000
539
RX3
7C
X006
6Fu
ll R
epor
t Ana
lysi
s
Pro
vidy
n N
etw
ork
Sec
urity
Sca
n -
Fire
wal
l5/
21/2
010
FTC
-PV
D-0
0084
0FT
C-P
VD
-000
864
RX3
8C
X007
2Fu
ll R
epor
t Ana
lysi
s P
rovi
dyn
Net
wor
k S
ecur
ity S
can
- S
peci
alty
VP
N5/
21/2
010
FTC
-PV
D-0
0113
8FT
C-P
VD
-001
161
RX3
9C
X007
3Fu
ll R
epor
t Ana
lysi
s P
rovi
dyn
Net
wor
k S
ecur
ity S
can
- N
etw
ork
Prin
ter
5/21
/201
0FT
C-P
VD
-001
162
FTC
-PV
D-0
0118
5R
X40
CX0
074
Full
Rep
ort A
naly
sis
Pro
vidy
n N
etw
ork
Sec
urity
Sca
n -
LabC
orp
VP
N5/
21/2
010
FTC
-PV
D-0
0118
6FT
C-P
VD
-001
210
RX4
5C
X025
3C
ypru
s C
omm
unic
atio
ns S
ervi
ces
Ord
erC
ypre
ss C
4 IP
Ser
vice
s O
rder
For
m1/
9/20
08FT
C-L
AB
MD
-000
246
FTC
-LA
BM
D-0
0024
9R
X46
CX0
264
Man
aged
Dat
a S
olut
ions
Invo
ice
MD
S In
voic
e4/
10/2
009
FTC
-LA
BM
D-0
0025
5FT
C-L
AB
MD
-000
255
RX6
0C
X016
2M
ail B
atch
Inst
ruct
ions
Mai
l Bat
ch In
stru
ctio
nsFT
C-L
AB
MD
-000
312
FTC
-LA
BM
D-0
0031
3R
X61
CX0
233
Dai
ly C
redi
t Car
d Tr
ansa
ctio
ns
Form
Dai
ly C
redi
t Car
d Tr
ansa
ctio
nsFT
C-L
AB
MD
-000
339
FTC
-LA
BM
D-0
0033
9R
X62
CX0
003
LabM
D N
ew T
eam
Mem
ber
Che
cklis
tN
ew T
eam
Mem
ber C
heck
list
FTC
-LA
BM
D-0
0036
6FT
C-L
AB
MD
-000
366
RX6
3C
X016
3P
atie
nt A
ging
Rep
ort
Pro
cess
for W
orki
ng A
ging
Rep
orts
FTC
-LA
BM
D-0
0037
7FT
C-L
AB
MD
-000
377
RX6
5C
X023
4La
bMD
Sta
ff R
espo
nsib
ility
br
eakd
own
Sta
ff In
foFT
C-L
AB
MD
-000
403
FTC
-LA
BM
D-0
0040
3R
X66
CX0
119
Jan
2007
Mon
thly
Sta
tus
of P
endi
ng
Task
s Fo
rmM
onth
ly S
tatu
s of
Pen
ding
Tas
ks
(1/2
007)
2/5/
2007
FTC
-LA
BM
D-0
0046
0FT
C-L
AB
MD
-000
462
RX6
7C
X013
4Li
st o
f clie
nts
with
rem
ote
acce
s to
La
bMD
sys
tem
LabM
D C
lient
s w
ith R
emot
e A
cces
sFT
C-L
AB
MD
-000
567
FTC
-LA
BM
D-0
0056
7R
X69
CX0
165
LabM
D In
sura
nce
Agi
ng R
epor
tLa
bMD
Insu
ranc
e A
ging
Rep
ort (
Cov
er
Pag
e)6/
5/20
07FT
C-L
AB
MD
-000
718
FTC
-LA
BM
D-0
0071
8R
X72
CX0
166
LabM
D In
sura
nce
Agi
ng R
epor
t (1
718
file)
Insu
ranc
e A
ging
Rep
ort -
Pag
e 1
Exc
erpt
6/5/
2007
FTC
-LA
BM
D-0
0077
7FT
C-L
AB
MD
-002
494
FTC
Doc
ket N
o. 9
357
Pag
e 2
of 1
7JX
0002
pag
e 4
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#R
X96
CX0
178
Ser
ver P
orts
and
Fire
wal
l Map
per
Map
per -
Ser
ver P
orts
& F
irew
all t
hrea
t su
mm
ary
6/18
/201
0FT
C-L
AB
MD
-002
616
FTC
-LA
BM
D-0
0261
6R
X170
CX0
185
Tren
dMic
ro D
aily
Viru
s R
epor
tTr
end
Mic
ro D
aily
Viru
s R
epor
t7/
10/2
010
FTC
-LA
BM
D-0
0308
4FT
C-L
AB
MD
-003
088
RX1
72C
X000
6La
bMD
Pol
icy
Man
ual
LabM
D P
olic
y M
anua
lFT
C-L
AB
MD
-003
141
FTC
-LA
BM
D-0
0316
2R
X173
CX0
004
LabM
D IT
Sta
ff W
alka
roun
d C
heck
list
IT W
alk
Aro
und
Che
cklis
t8/
6/20
07FT
C-L
AB
MD
-003
164
FTC
-LA
BM
D-0
0316
4R
X182
CX0
236
LabM
D e
mai
l re:
Dai
ly IT
Rou
nds
Em
ail S
ubje
ct: D
aily
IT ro
unds
8/22
/200
7FT
C-L
AB
MD
-003
175
FTC
-LA
BM
D-0
0317
5R
X212
CX0
199
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
Em
ail S
ubje
ct: D
aily
IT ro
unds
11/2
1/20
07FT
C-L
AB
MD
-003
213
FTC
-LA
BM
D-0
0321
3R
X265
CX0
257
ZyXe
l Fire
wal
l Rul
es S
tora
ge S
pace
in
Use
ZyXE
L Fi
rew
all R
ules
FTC
-LA
BM
D-0
0326
8FT
C-L
AB
MD
-003
268
RX2
66C
X012
6La
bMD
Ser
ver R
oom
Sec
urity
Cha
rt - J
un 2
010
Ser
ver U
pdat
es (i
ncl.
Sal
es R
epor
ts)
6/11
/201
0FT
C-L
AB
MD
-003
274
FTC
-LA
BM
D-0
0327
4R
X267
CX0
126
LabM
D S
erve
r Roo
m S
ecur
ity C
hart
- Jul
201
0S
erve
r Upd
ates
(inc
l. S
ales
Rep
orts
)7/
5/20
10FT
C-L
AB
MD
-003
275
FTC
-LA
BM
D-0
0327
5R
X268
CX0
268
Mal
war
e Q
uick
scan
Log
mba
m lo
g7/
15/2
010
FTC
-LA
BM
D-0
0328
4FT
C-L
AB
MD
-003
286
RX2
69C
X081
8M
alw
are
Qui
cksc
an L
ogm
bam
log
(14-
12-3
6)7/
15/2
010
FTC
-LA
BM
D-0
0329
3FT
C-L
AB
MD
-003
293
RX2
71C
X082
5S
ecur
ity s
can
resu
ltsM
icro
soft
Win
dow
s A
pp F
irew
all
Byp
ass
FTC
-LA
BM
D-0
0331
6FT
C-L
AB
MD
-003
317
RX2
72C
X083
0S
ecur
ity S
can
Res
ults
Mic
roso
ft W
indo
ws
App
Fire
wal
l B
ypas
s -
Win
dow
s S
ecur
ity C
ente
r A
ntiV
irus
Ove
rrid
eFT
C-L
AB
MD
-003
343
FTC
-LA
BM
D-0
0334
3R
X273
CX0
169
Pro
duct
Key
Cha
rtIT
Too
ls/C
heck
s-ha
ndw
ritte
n -
Adm
inis
trato
rs O
ld C
ompu
ter
FTC
-LA
BM
D-0
0334
4FT
C-L
AB
MD
-003
344
RX2
74C
X019
3Ju
ly 2
010
Sec
urity
Sca
n Li
stV
irus/
Mal
war
e R
esul
ts -
July
201
07/
30/2
010
FTC
-LA
BM
D-0
0335
0FT
C-L
AB
MD
-003
358
RX2
88C
X083
2M
alw
are
Qui
cksc
an L
ogm
bam
logs
-Map
per
FTC
-LA
BM
D-0
0342
8FT
C-L
AB
MD
-003
428
RX2
98C
X083
2M
alw
are
Qui
cksc
an L
ogm
bam
logs
-Map
per
FTC
-LA
BM
D-0
0343
8FT
C-L
AB
MD
-003
438
FTC
Doc
ket N
o. 9
357
Pag
e 3
of 1
7JX
0002
pag
e 5
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#R
X304
CX0
833
Mal
war
e Q
uick
scan
Log
mba
m lo
gs-V
isne
tic7/
31/2
010
FTC
-LA
BM
D-0
0344
4FT
C-L
AB
MD
-003
444
RX3
06C
X039
5A
utom
ated
PC
Tec
hnol
ogie
s N
ew
Ser
vice
Agr
eem
ent
New
AP
T se
rvic
e ag
reem
ent
2/23
/200
6FT
C-L
AB
MD
-003
471
FTC
-LA
BM
D-0
0347
4R
X307
CX0
035
AP
T S
ervi
ce In
voic
eA
utom
ated
PC
Tec
hnol
ogie
s, In
c.
("A
PT"
) Ser
vice
Invo
ice
FTC
-LA
BM
D-0
0347
5FT
C-L
AB
MD
-003
482
RX3
08C
X020
3C
hris
toph
er M
aire
resu
me
Chr
isto
pher
Mai
re R
esum
eFT
C-L
AB
MD
-003
488
FTC
-LA
BM
D-0
0348
9R
X309
CX0
005
LabM
D C
ompl
ianc
e P
rogr
am
LabM
D C
ompl
ianc
e P
rogr
am e
ffect
ive
Jan.
200
3Ja
n-03
FTC
-LA
BM
D-0
0349
3FT
C-L
AB
MD
-003
502
RX3
10C
X012
7La
bMD
Com
plia
nce
Trai
ning
P
ower
poin
tC
ompl
ianc
e Tr
aini
ng P
ower
Poi
nt
Slid
esFT
C-L
AB
MD
-003
503
FTC
-LA
BM
D-0
0353
0R
X312
CX0
170
Em
ail b
etw
een
San
dra
Bro
wn
and
John
Boy
le re
: Lim
ewire
issu
esE
mai
l S. B
row
n to
J. B
oyle
Sub
ject
: Li
mew
ire Is
sue
8/12
/201
0FT
C-L
AB
MD
-003
587
FTC
-LA
BM
D-0
0358
7R
X316
CX0
834
Pat
holo
gy R
ecor
ds a
nd M
ater
ials
R
eten
tion
Pat
holo
gy R
ecor
ds a
nd M
ater
ials
R
eten
tion
May
-09
FTC
-LA
BM
D-0
0363
5FT
C-L
AB
MD
-003
635
RX3
17C
X004
6M
anag
ed D
ata
Sol
utio
ns S
ecur
ity
Sca
n S
umm
ary
Man
aged
Dat
a S
olut
ions
("M
DS
")
Sta
tem
ent o
f Wor
k fo
r Lab
MD
re:
pene
tratio
n te
stin
gFT
C-L
AB
MD
-003
636
FTC
-LA
BM
D-0
0364
5R
X318
CX0
039
LabM
D c
onne
ctio
ns m
ap fo
r Pow
er
Ferr
y R
d lo
catio
n- 2
009
Net
wor
k D
iagr
am -
Pow
ers
Ferr
y R
oad
Loca
tion
Apr
. 200
9A
pr-0
9FT
C-L
AB
MD
-003
646
FTC
-LA
BM
D-0
0364
6R
X319
CX0
040
LabM
D c
onne
ctio
ns m
ap fo
r Pow
er
Ferr
y R
d lo
catio
n- 2
010
Net
wor
k D
iagr
am -
Pow
ers
Ferr
y R
oad
Loca
tion
Sep
t. 20
10S
ep-1
0FT
C-L
AB
MD
-003
647
FTC
-LA
BM
D-0
0364
7R
X320
CX0
041
LabM
D c
onne
ctio
ns m
ap fo
r Pow
er
Ferr
y R
d lo
catio
n- 2
011
Net
wor
k D
iagr
am -
Pow
ers
Ferr
y R
oad
Loca
tion
2011
FTC
-LA
BM
D-0
0364
8FT
C-L
AB
MD
-003
648
RX3
22C
X032
0B
rand
on B
radl
ey re
sum
eB
rand
on B
radl
ey R
esum
eFT
C-L
AB
MD
-003
657
FTC
-LA
BM
D-0
0365
8R
X325
CX0
194
Man
aged
Dat
a S
olut
ions
Pro
ject
P
ropo
sal
MD
S P
roje
ct P
ropo
sal -
Web
sens
e4/
12/2
011
FTC
-LA
BM
D-0
0373
8FT
C-L
AB
MD
-003
739
RX3
26C
X019
5M
anag
ed D
ata
Sol
utio
ns P
roje
ct
Pro
posa
lM
DS
Pro
ject
Pro
posa
l - W
ebse
nse
Tim
e P
ortio
n4/
12/2
011
FTC
-LA
BM
D-0
0374
0FT
C-L
AB
MD
-003
740
FTC
Doc
ket N
o. 9
357
Pag
e 4
of 1
7JX
0002
pag
e 6
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#
RX3
27C
X014
9C
X015
0C
X015
1C
X015
2Ti
vers
a fo
lder
scr
eens
hot
CX0
149:
Scr
eens
hot:
LabM
D -
Tive
rsa.
zip-
WIN
RA
R -
insu
ranc
eagi
ng_6
.05.
071.
CX0
150:
Scr
eens
hot:
C:\
CX0
151:
Scr
eens
hot:
C:\P
rogr
am
File
s\Li
meW
ireC
X015
2: S
cree
nsho
t: Li
meW
ire: M
y S
hare
d Fi
les
FTC
-LA
BM
D-0
0375
2FT
C-L
AB
MD
-003
755
RX3
28C
X015
3La
bMD
fold
er s
cree
nsho
tS
cree
nsho
t: La
bMD
- Ti
vers
a.zi
p W
inR
AR
- La
bMD
fold
erFT
C-L
AB
MD
-003
757
FTC
-LA
BM
D-0
0375
7
RX3
29C
X015
4C
X015
5C
X015
6Li
mew
ire s
cree
nsho
t
CX0
154:
Scr
eens
hot:
Lim
eWire
Get
S
tarte
dC
X015
5: S
cree
nsho
t: S
tart
Men
u:
Lim
eWire
CX0
156:
Scr
eens
hot:
Lim
eWire
: O
ptio
ns: S
hare
d Fo
lder
sFT
C-L
AB
MD
-003
758
FTC
-LA
BM
D-0
0376
0
RX3
30C
X015
7In
sura
nce
Agi
ng p
df w
indo
w
scre
ensh
ot
Scr
eens
hot:
insu
ranc
eagi
ng_6
.05.
071.
Pro
perti
es5/
14/2
008
FTC
-LA
BM
D-0
0376
1FT
C-L
AB
MD
-003
761
RX3
31C
X010
1S
acP
D N
etan
alys
is re
: Mal
dona
do
and
Gar
cia
SP
D N
etA
naly
sis
Rep
ort
FTC
-SA
C-0
0067
9FT
C-S
AC
-000
682
RX3
32C
X022
5Le
tter t
o M
. Cox
from
R.J
. Max
ay
Lette
r fro
m S
outh
east
Uro
logy
Net
wor
k12
/6/2
013
FTC
-SU
N-0
0000
1FT
C-S
UN
-000
003
RX3
34C
X012
9La
bMD
Com
plia
nce
Pro
gram
La
bMD
Com
plia
nce
Pro
gram
- ef
fect
ive
Jan.
200
3, s
igna
ture
pag
esJa
n-03
FTC
-LA
BM
D-0
0376
3FT
C-L
AB
MD
-003
776
RX3
36C
X013
0La
bMD
Em
ploy
ee H
andb
ook
LabM
D E
mpl
oyee
Han
dboo
k R
ev. O
ct.
2007
- si
gnat
ure
page
sO
ct-0
7FT
C-L
AB
MD
-003
819
FTC
-LA
BM
D-0
0386
5R
X344
CX0
397
LabM
D "N
etw
ork
Inve
nt" s
umm
ary
Rec
ordI
nven
t12
/22/
2013
FTC
-ALT
-000
0001
FTC
-ALT
-000
0003
RX3
45C
X039
8A
utom
ated
PC
Tec
hnol
ogie
s In
voic
eA
PT
Ser
vice
Invo
ice
FTC
-ALT
-000
0004
FTC
-ALT
-000
0011
RX3
56C
X029
0
Uno
ffici
al p
roto
col f
or d
ocum
ent
trans
mis
sion
bet
wee
n La
bMD
and
M
idto
wn
Uro
logy
Mid
tow
n U
rolo
gy U
noffi
cial
Pro
toco
l of
Pat
ient
Info
rmat
ion
Tran
smitt
alFT
C-M
ID-0
0000
9FT
C-M
ID-0
0001
0R
X357
CX0
291
LabM
D c
losu
re a
nnou
ncem
ent
LabM
D L
ette
r to
Phy
sici
ans
Offi
ces
re:
Clo
sing
1/6/
2014
FTC
-MID
-000
011
FTC
-MID
-000
012
FTC
Doc
ket N
o. 9
357
Pag
e 5
of 1
7JX
0002
pag
e 7
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#R
X362
CX0
313
LabM
D IT
pro
ject
out
line
LabM
D IT
Pro
ject
Out
line
- Net
wor
k,
Har
dwar
e, S
oftw
are
chan
ges
FTC
-LA
BM
D-0
0439
4FT
C-L
AB
MD
-004
395
RX4
12C
X068
3IT
exp
endi
ture
cha
rtS
prea
dshe
et o
f IT
Exp
endi
ture
s 20
05-
2013
nat
ive
file
FTC
-LA
BM
D-0
1618
4FT
C-L
AB
MD
-016
221
RX4
82C
X067
8C
ypru
s M
aste
r Ter
ms
Cyp
ress
Mas
ter T
erm
s an
d C
ondi
tions
(B
ates
-labe
led
vers
ion)
8/11
/200
8(F
TC-C
YP-0
0015
54)
(FTC
-CYP
-000
1570
)R
X521
CX0
085
RX3
Yod
aike
n de
posi
tion
LabM
D D
ay S
heet
s an
d C
opie
d C
heck
sFT
C-S
AC
-000
001
FTC
-SA
C-0
0004
4
CX0
770
FTC
Con
sum
er A
lert:
File
-Sha
ring:
A
Fair
Sha
re?
May
be N
ot7/
29/2
003
FTC
-000
685
FTC
-000
689
CX0
771
Pre
ss R
elea
se: C
ounc
il of
Bet
ter
Bus
ines
s B
urea
us, N
atio
nal C
yber
S
ecur
ity A
llian
ce, F
eder
al T
rade
C
omm
issi
on, O
ffer B
usin
esse
s Ti
ps
For K
eepi
ng T
heir
Com
pute
r Sys
tem
s S
ecur
e4/
2/20
04FT
C-0
0069
0FT
C-0
0069
2
CX0
772
Pre
ss R
elea
se: F
TC T
estif
ies
on P
eer
to P
eer F
ile S
harin
g an
d O
nlin
e P
orno
grap
hy5/
6/20
04FT
C-0
0069
3FT
C-0
0069
4
CX0
773
Pre
pare
d S
tate
men
t of F
TC: H
earin
g on
Onl
ine
Por
nogr
aphy
: Clo
sing
the
Doo
r on
Per
vasi
ve S
mut
5/6/
2004
FTC
-000
695
FTC
-000
705
CX0
774
Pre
ss R
elea
se: P
eer-
to-P
eer F
ile-
Sha
ring
Ris
ks C
an B
e B
ette
r Dis
clos
ed6/
23/2
004
FTC
-000
706
FTC
-000
707
CX0
775
Pre
pare
d S
tate
men
t of F
TC: H
earin
g on
P2P
File
-Sha
ring
Tech
nolo
gy6/
23/2
004
FTC
-000
708
FTC
-000
717
CX0
776
Pre
ss R
elea
se: F
TC Is
sues
Rep
ort o
n P
eer-
to-P
eer F
ile S
harin
g6/
23/2
005
FTC
-000
718
FTC
-000
719
CX0
777
FTC
Sta
ff R
epor
t: P
eer-
to-P
eer F
ile-
Sha
ring
Tech
nolo
gy: C
onsu
mer
P
rote
ctio
n an
d C
ompe
titio
n Is
sues
: A
Fede
ral T
rade
Com
mis
sion
Sta
ff W
orks
hop
Rep
ort
6/23
/200
5FT
C-0
0072
0FT
C-0
0080
6
Cat
egor
y 2:
Non
-sha
red
Exhi
bits
to w
hich
Nei
ther
Par
ty O
bjec
ts
FTC
Doc
ket N
o. 9
357
Pag
e 6
of 1
7JX
0002
pag
e 8
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#
CX0
778
Rev
ised
FTC
Con
sum
er A
lert:
P2P
File
-S
harin
g: E
valu
atin
g th
e R
isks
6/23
/200
5FT
C-0
0080
7FT
C-0
0081
1
CX0
779
Rev
ised
FTC
Con
sum
er A
lert:
P2P
File
-S
harin
g: E
valu
atin
g th
e R
isks
7/18
/200
5FT
C-0
0081
2FT
C-0
0081
7
CX0
780
Rev
ised
FTC
Spa
nish
Con
sum
er A
lert:
Fi
le-S
harin
g: E
valu
atin
g th
e R
isks
8/18
/200
5FT
C-0
0081
8FT
C-0
0082
3
CX0
781
FTC
Dis
tribu
tion:
Sto
p.Th
ink.
Clic
k: 7
P
ract
ices
for S
afer
Com
putin
g9/
16/2
005
FTC
-000
824
FTC
-000
832
CX0
782
FTC
Spa
nish
Dis
tribu
tion:
Sto
p. T
hink
. C
lick
broc
hure
10/2
8/20
05FT
C-0
0083
3FT
C-0
0084
3
CX0
783
FTC
Spa
nish
Dis
tribu
tion:
New
ver
sion
of
Sto
p. T
hink
. Clic
k br
ochu
re11
/4/2
005
FTC
-000
844
FTC
-000
852
CX0
784
FTC
Dis
tribu
tion:
Rev
ised
P2P
File
S
harin
g: E
valu
ate
the
Ris
ks12
/9/2
006
FTC
-000
853
FTC
-000
857
CX0
785
Rev
ised
FTC
Spa
nish
Con
sum
er A
lert:
Fi
le-S
harin
g: E
valu
atin
g th
e R
isks
2/27
/200
7FT
C-0
0085
8FT
C-0
0086
3
CX0
786
Pre
ss R
elea
se: F
TC T
estif
ies
on
Pot
entia
l Ris
ks o
f Pee
r-to
-Pee
r File
S
harin
g7/
24/2
007
FTC
-000
864
FTC
-000
865
CX0
787
Pre
pare
d S
tate
men
t of F
TC o
n P
eer-
To-
Pee
r File
-Sha
ring
Tech
nolo
gy Is
sues
7/24
/200
7FT
C-0
0086
6FT
C-0
0087
7
CX0
788
FTC
Dis
tribu
tion:
Rev
ised
P2P
File
S
harin
g: E
valu
ate
the
Ris
ks4/
30/2
008
FTC
-000
878
FTC
-000
886
CX0
789
Rev
ised
FTC
Spa
nish
Con
sum
er A
lert:
Fi
le-S
harin
g: E
valu
atin
g th
e R
isks
4/30
/200
8FT
C-0
0088
7FT
C-0
0089
3
RX2
Insu
ranc
e co
mpa
ny w
eb a
cces
s sh
eet
9/12
/200
7FT
C-0
0027
9FT
C-0
0027
9R
X3IT
Sta
ff C
heck
list
FTC
-000
366
FTC
-000
367
RX4
web
site
list
FTC
-000
370
FTC
-000
375
RX5
win
dow
s sc
reen
shot
FTC
-000
376
FTC
-000
376
RX1
6C
alen
dar M
eetin
g R
eque
st
5/14
/201
0FT
C-P
VD
-000
041
FTC
-PV
D-0
0004
1R
X17
Cal
enda
r Mee
ting
Req
uest
5/
24/2
010
FTC
-PV
D-0
0004
2FT
C-P
VD
-000
042
RX1
8C
alen
dar M
eetin
g R
eque
st
7/16
/201
0FT
C-P
VD
-000
043
FTC
-PV
D-0
0004
3
RX1
9Le
tter f
rom
Mik
e D
augh
erty
to
Pro
viD
yn, I
nc.
5/28
/201
0FT
C-P
VD
-000
044
FTC
-PV
D-0
0004
4
FTC
Doc
ket N
o. 9
357
Pag
e 7
of 1
7JX
0002
pag
e 9
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#
RX2
0S
ervi
ce S
olut
ions
Pro
posa
l for
La
bMD
from
Pro
viD
yn20
10FT
C-P
VD
-000
045
FTC
-PV
D-0
0004
8R
X23
Full
Rep
ort A
naly
sis
7/28
/201
0FT
C-P
VD
-000
175
FTC
-PV
D-0
0020
1R
X31
Full
Rep
ort A
naly
sis
9/3/
2010
FTC
-PV
D-0
0054
1FT
C-P
VD
-000
567
RX3
2Fu
ll R
epor
t Ana
lysi
s 9/
3/20
10FT
C-P
VD
-000
592
FTC
-PV
D-0
0061
5R
X33
Full
Rep
ort A
naly
sis
9/3/
2010
FTC
-PV
D-0
0061
6FT
C-P
VD
-000
639
RX3
4Fu
ll R
epor
t Ana
lysi
s 9/
3/20
10FT
C-P
VD
-000
640
FTC
-PV
D-0
0066
4R
X35
Full
Rep
ort A
naly
sis
9/3/
2010
FTC
-PV
D-0
0066
5FT
C-P
VD
-000
689
RX3
6Fu
ll R
epor
t Ana
lysi
s 9/
3/20
10FT
C-P
VD
-000
739
FTC
-PV
D-0
0081
1
RX4
1E
mai
l fro
m J
. Boy
le to
R. B
obac
k re
: B
reac
h N
otifi
catio
nR
X47
Med
iPro
Sal
e In
voic
es11
/18/
2008
FTC
-LA
BM
D-0
0026
4FT
C-L
AB
MD
-000
267
RX4
8M
ediP
ro S
ales
Invo
ice
11/1
3/20
08FT
C-L
AB
MD
-000
268
FTC
-LA
BM
D-0
0026
8R
X49
Med
iPro
Sal
es IN
voic
e4/
4/20
07FT
C-L
AB
MD
-000
269
FTC
-LA
BM
D-0
0026
9R
X50
Em
ail b
etw
een
Boy
le a
nd T
iver
sa5/
13/2
008
FTC
-LA
BM
D-0
0028
7FT
C-L
AB
MD
-000
287
RX5
1E
mai
l bet
wee
n B
oyle
and
Tiv
ersa
5/13
/200
8FT
C-L
AB
MD
-000
288
FTC
-LA
BM
D-0
0028
8R
X52
Em
ail b
etw
een
Boy
le a
nd T
iver
sa5/
13/2
008
FTC
-LA
BM
D-0
0029
0FT
C-L
AB
MD
-000
290
RX5
3E
mai
l bet
wee
n B
oyle
, Dau
gher
ty,
and
Tive
rsa
5/15
/200
8FT
C-L
AB
MD
-000
291
FTC
-LA
BM
D-0
0029
3R
X54
Em
ail b
etw
een
Boy
le a
nd T
iver
sa5/
22/2
008
FTC
-LA
BM
D-0
0029
4FT
C-L
AB
MD
-000
294
RX5
5E
mai
l bet
wee
n B
oyle
and
Tiv
ersa
5/23
/200
8FT
C-L
AB
MD
-000
295
FTC
-LA
BM
D-0
0029
8R
X56
Em
ail b
etw
een
Boy
le a
nd T
iver
sa5/
30/2
008
FTC
-LA
BM
D-0
0029
9FT
C-L
AB
MD
-000
299
RX5
7E
mai
l bet
wee
n B
oyle
and
Tiv
ersa
6/6/
2008
FTC
-LA
BM
D-0
0030
0FT
C-L
AB
MD
-000
300
RX5
8E
mai
l bet
wee
n B
oyle
and
Dau
gher
ty
re: b
reac
h6/
15/2
008
FTC
-LA
BM
D-0
0030
1FT
C-L
AB
MD
-000
302
RX5
9E
mai
l bet
wee
n B
oyle
and
Tiv
ersa
re
: bre
ach
7/22
/200
8FT
C-L
AB
MD
-000
303
FTC
-LA
BM
D-0
0030
3R
X70
LabM
D C
ompl
ianc
e P
rogr
amFT
C-L
AB
MD
-000
719
FTC
-LA
BM
D-0
0072
8R
X71
LabM
D E
mpl
oyee
Han
dboo
kFT
C-L
AB
MD
-000
732
FTC
-LA
BM
D-0
0075
3
RX7
3C
ertif
icat
ion
page
sig
ned
by
Dau
gher
ty7/
14/2
010
FTC
-LA
BM
D-0
0252
2FT
C-L
AB
MD
-002
522
RX7
4La
bMD
Com
pute
r Har
dwar
e an
d S
ecur
ity M
anua
lFT
C-L
AB
MD
-002
525
FTC
-LA
BM
D-0
0255
6R
X97
Dai
ly IT
Wal
k5/
27/2
008
FTC
-LA
BM
D-0
0263
6FT
C-L
AB
MD
-002
636
RX9
8D
aily
IT W
alk
5/28
/200
8FT
C-L
AB
MD
-002
637
FTC
-LA
BM
D-0
0263
7R
X99
Dai
ly IT
Wal
k6/
2/20
08FT
C-L
AB
MD
-002
638
FTC
-LA
BM
D-0
0263
8
FTC
Doc
ket N
o. 9
357
Pag
e 8
of 1
7JX
0002
pag
e 10
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#R
X100
Dai
ly IT
Wal
k6/
3/20
08FT
C-L
AB
MD
-002
639
FTC
-LA
BM
D-0
0263
9R
X101
Dai
ly IT
Wal
k6/
4/20
08FT
C-L
AB
MD
-002
640
FTC
-LA
BM
D-0
0264
0R
X102
Dai
ly IT
Wal
k6/
5/20
08FT
C-L
AB
MD
-002
641
FTC
-LA
BM
D-0
0264
1R
X103
Dai
ly IT
Wal
k6/
6/20
08FT
C-L
AB
MD
-002
642
FTC
-LA
BM
D-0
0264
2R
X104
Dai
ly IT
Wal
k6/
10/2
008
FTC
-LA
BM
D-0
0264
3FT
C-L
AB
MD
-002
643
RX1
05D
aily
IT W
alk
6/11
/200
8FT
C-L
AB
MD
-002
644
FTC
-LA
BM
D-0
0264
4R
X106
Dai
ly IT
Wal
k6/
12/2
008
FTC
-LA
BM
D-0
0264
5FT
C-L
AB
MD
-002
645
RX1
07D
aily
IT W
alk
6/17
/200
8FT
C-L
AB
MD
-002
646
FTC
-LA
BM
D-0
0264
6R
X108
Dai
ly IT
Wal
k7/
2/20
08FT
C-L
AB
MD
-002
647
FTC
-LA
BM
D-0
0264
7R
X109
Dai
ly IT
Wal
k7/
3/20
08FT
C-L
AB
MD
-002
648
FTC
-LA
BM
D-0
0264
8R
X110
Dai
ly IT
Wal
k7/
10/2
008
FTC
-LA
BM
D-0
0264
9FT
C-L
AB
MD
-002
649
RX1
11D
aily
IT W
alk
7/14
/200
8FT
C-L
AB
MD
-002
650
FTC
-LA
BM
D-0
0265
0R
X112
Dai
ly IT
Wal
k7/
15/2
008
FTC
-LA
BM
D-0
0265
1FT
C-L
AB
MD
-002
651
RX1
13D
aily
IT W
alk
7/16
/200
8FT
C-L
AB
MD
-002
652
FTC
-LA
BM
D-0
0265
2R
X114
Dai
ly IT
Wal
k7/
18/2
008
FTC
-LA
BM
D-0
0265
3FT
C-L
AB
MD
-002
653
RX1
15D
aily
IT W
alk
7/22
/200
8FT
C-L
AB
MD
-002
654
FTC
-LA
BM
D-0
0265
4R
X116
Dai
ly IT
Wal
k7/
29/2
008
FTC
-LA
BM
D-0
0265
5FT
C-L
AB
MD
-002
655
RX1
17D
aily
IT W
alk
7/30
/200
8FT
C-L
AB
MD
-002
656
FTC
-LA
BM
D-0
0265
6R
X118
Dai
ly IT
Wal
k7/
31/2
008
FTC
-LA
BM
D-0
0265
7FT
C-L
AB
MD
-002
657
RX1
19La
bMD
em
ail r
e: w
alk
arou
nds
3/12
/200
9FT
C-L
AB
MD
-002
658
FTC
-LA
BM
D-0
0265
8R
X120
LabM
D e
mai
l re:
wal
k ar
ound
s3/
13/2
009
FTC
-LA
BM
D-0
0265
9FT
C-L
AB
MD
-002
659
RX1
21La
bMD
em
ail r
e: w
alk
arou
nds
3/17
/200
9FT
C-L
AB
MD
-002
660
FTC
-LA
BM
D-0
0266
0R
X122
LabM
D e
mai
l re:
wal
k ar
ound
s3/
23/2
009
FTC
-LA
BM
D-0
0266
1FT
C-L
AB
MD
-002
661
RX1
23La
bMD
em
ail r
e: w
alk
arou
nds
3/30
/200
9FT
C-L
AB
MD
-002
662
FTC
-LA
BM
D-0
0266
2R
X124
LabM
D e
mai
l re:
wal
k ar
ound
s4/
1/20
09FT
C-L
AB
MD
-002
663
FTC
-LA
BM
D-0
0266
3R
X125
LabM
D e
mai
l re:
wal
k ar
ound
s4/
3/20
09FT
C-L
AB
MD
-002
664
FTC
-LA
BM
D-0
0266
4R
X126
LabM
D e
mai
l re:
wal
k ar
ound
s4/
6/20
09FT
C-L
AB
MD
-002
665
FTC
-LA
BM
D-0
0266
5R
X127
LabM
D e
mai
l re:
wal
k ar
ound
s4/
10/2
009
FTC
-LA
BM
D-0
0266
6FT
C-L
AB
MD
-002
666
RX1
28La
bMD
em
ail r
e: w
alk
arou
nds
4/13
/200
9FT
C-L
AB
MD
-002
667
FTC
-LA
BM
D-0
0266
7R
X129
LabM
D e
mai
l re:
wal
k ar
ound
s4/
16/2
009
FTC
-LA
BM
D-0
0266
8FT
C-L
AB
MD
-002
668
RX1
30La
bMD
em
ail r
e: w
alk
arou
nds
5/19
/200
9FT
C-L
AB
MD
-002
669
FTC
-LA
BM
D-0
0266
9R
X131
LabM
D e
mai
l re:
wal
k ar
ound
s5/
20/2
009
FTC
-LA
BM
D-0
0267
0FT
C-L
AB
MD
-002
670
RX1
32La
bMD
em
ail r
e: w
alk
arou
nds
5/22
/200
9FT
C-L
AB
MD
-002
671
FTC
-LA
BM
D-0
0267
1R
X133
LabM
D e
mai
l re:
wal
k ar
ound
s5/
26/2
009
FTC
-LA
BM
D-0
0267
2FT
C-L
AB
MD
-002
672
RX1
34La
bMD
em
ail r
e: w
alk
arou
nds
6/2/
2009
FTC
-LA
BM
D-0
0267
3FT
C-L
AB
MD
-002
673
RX1
35La
bMD
em
ail r
e: w
alk
arou
nds
6/11
/200
9FT
C-L
AB
MD
-002
674
FTC
-LA
BM
D-0
0267
4
FTC
Doc
ket N
o. 9
357
Pag
e 9
of 1
7JX
0002
pag
e 11
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#R
X136
LabM
D e
mai
l re:
wal
k ar
ound
s6/
12/2
009
FTC
-LA
BM
D-0
0267
5FT
C-L
AB
MD
-002
675
RX1
37La
bMD
em
ail r
e: w
alk
arou
nds
6/15
/200
9FT
C-L
AB
MD
-002
676
FTC
-LA
BM
D-0
0267
6R
X138
LabM
D e
mai
l re:
wal
k ar
ound
s6/
16/2
009
FTC
-LA
BM
D-0
0267
7FT
C-L
AB
MD
-002
677
RX1
39La
bMD
em
ail r
e: w
alk
arou
nds
6/17
/200
9FT
C-L
AB
MD
-002
678
FTC
-LA
BM
D-0
0267
8R
X140
LabM
D e
mai
l re:
wal
k ar
ound
s6/
18/2
009
FTC
-LA
BM
D-0
0267
9FT
C-L
AB
MD
-002
679
RX1
41La
bMD
em
ail r
e: w
alk
arou
nds
6/19
/200
9FT
C-L
AB
MD
-002
680
FTC
-LA
BM
D-0
0268
0R
X142
LabM
D e
mai
l re:
wal
k ar
ound
s6/
22/2
009
FTC
-LA
BM
D-0
0268
1FT
C-L
AB
MD
-002
681
RX1
43La
bMD
em
ail r
e: w
alk
arou
nds
6/23
/200
9FT
C-L
AB
MD
-002
682
FTC
-LA
BM
D-0
0268
2R
X144
LabM
D e
mai
l re:
wal
k ar
ound
s6/
23/2
009
FTC
-LA
BM
D-0
0268
3FT
C-L
AB
MD
-002
683
RX1
45La
bMD
em
ail r
e: w
alk
arou
nds
6/24
/200
9FT
C-L
AB
MD
-002
684
FTC
-LA
BM
D-0
0268
4R
X146
LabM
D e
mai
l re:
wal
k ar
ound
s6/
25/2
009
FTC
-LA
BM
D-0
0268
5FT
C-L
AB
MD
-002
685
RX1
47La
bMD
em
ail r
e: w
alk
arou
nds
6/26
/200
9FT
C-L
AB
MD
-002
686
FTC
-LA
BM
D-0
0268
6R
X148
LabM
D e
mai
l re:
wal
k ar
ound
s6/
29/2
009
FTC
-LA
BM
D-0
0268
7FT
C-L
AB
MD
-002
687
RX1
49La
bMD
em
ail r
e: w
alk
arou
nds
7/24
/200
9FT
C-L
AB
MD
-002
688
FTC
-LA
BM
D-0
0268
8R
X150
LabM
D e
mai
l re:
wal
k ar
ound
s7/
25/2
009
FTC
-LA
BM
D-0
0268
9FT
C-L
AB
MD
-002
689
RX1
51La
bMD
em
ail r
e: w
alk
arou
nds
7/17
/200
9FT
C-L
AB
MD
-002
690
FTC
-LA
BM
D-0
0269
0R
X152
LabM
D e
mai
l re:
wal
k ar
ound
s7/
20/2
009
FTC
-LA
BM
D-0
0269
1FT
C-L
AB
MD
-002
691
RX1
53La
bMD
em
ail r
e: w
alk
arou
nds
7/21
/200
9FT
C-L
AB
MD
-002
692
FTC
-LA
BM
D-0
0269
2R
X154
LabM
D e
mai
l re:
wal
k ar
ound
s7/
22/2
009
FTC
-LA
BM
D-0
0269
3FT
C-L
AB
MD
-002
693
RX1
55La
bMD
em
ail r
e: w
alk
arou
nds
7/24
/200
9FT
C-L
AB
MD
-002
694
FTC
-LA
BM
D-0
0269
4R
X156
LabM
D e
mai
l re:
wal
k ar
ound
s7/
27/2
009
FTC
-LA
BM
D-0
0269
5FT
C-L
AB
MD
-002
695
RX1
57La
bMD
em
ail r
e: w
alk
arou
nds
7/28
/200
9FT
C-L
AB
MD
-002
696
FTC
-LA
BM
D-0
0269
6R
X158
LabM
D e
mai
l re:
wal
k ar
ound
s7/
29/2
009
FTC
-LA
BM
D-0
0269
7FT
C-L
AB
MD
-002
697
RX1
59La
bMD
em
ail r
e: w
alk
arou
nds
7/31
/200
9FT
C-L
AB
MD
-002
698
FTC
-LA
BM
D-0
0269
8R
X160
LabM
D e
mai
l re:
wal
k ar
ound
s8/
2/20
09FT
C-L
AB
MD
-002
699
FTC
-LA
BM
D-0
0269
9R
X161
LabM
D e
mai
l re:
wal
k ar
ound
s8/
4/20
09FT
C-L
AB
MD
-002
700
FTC
-LA
BM
D-0
0270
0R
X162
LabM
D e
mai
l re:
wal
k ar
ound
s8/
5/20
09FT
C-L
AB
MD
-002
701
FTC
-LA
BM
D-0
0270
1R
X163
LabM
D e
mai
l re:
wal
k ar
ound
s8/
10/2
009
FTC
-LA
BM
D-0
0270
2FT
C-L
AB
MD
-002
702
RX1
64La
bMD
em
ail r
e: w
alk
arou
nds
8/11
/200
9FT
C-L
AB
MD
-002
703
FTC
-LA
BM
D-0
0270
3R
X165
LabM
D e
mai
l re:
wal
k ar
ound
s8/
12/2
009
FTC
-LA
BM
D-0
0270
4FT
C-L
AB
MD
-002
704
RX1
66La
bMD
em
ail r
e: w
alk
arou
nds
8/13
/200
9FT
C-L
AB
MD
-002
705
FTC
-LA
BM
D-0
0270
5R
X167
LabM
D e
mai
l re:
wal
k ar
ound
s8/
14/2
009
FTC
-LA
BM
D-0
0270
6FT
C-L
AB
MD
-002
706
RX1
68La
bMD
em
ail r
e: w
alk
arou
nds
8/18
/200
9FT
C-L
AB
MD
-002
711
FTC
-LA
BM
D-0
0271
1R
X169
LabM
D e
mai
l re:
wal
k ar
ound
s8/
28/2
009
FTC
-LA
BM
D-0
0271
4FT
C-L
AB
MD
-002
714
RX1
71La
bMD
Viru
s Lo
gFT
C-L
AB
MD
-003
124
FTC
-LA
BM
D-0
0312
7R
X174
LabM
D e
mai
l re:
Dai
ly IT
Rou
nds
8/7/
2007
FTC
-LA
BM
D-0
0316
6FT
C-L
AB
MD
-003
166
FTC
Doc
ket N
o. 9
357
Pag
e 10
of 1
7JX
0002
pag
e 12
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#R
X175
LabM
D e
mai
l re:
Dai
ly IT
Rou
nds
8/8/
2007
FTC
-LA
BM
D-0
0316
7FT
C-L
AB
MD
-003
167
RX1
76La
bMD
em
ail r
e: D
aily
IT R
ound
s8/
13/2
007
FTC
-LA
BM
D-0
0316
8FT
C-L
AB
MD
-003
168
RX1
77La
bMD
em
ail r
e: D
aily
IT R
ound
s8/
14/2
007
FTC
-LA
BM
D-0
0316
9FT
C-L
AB
MD
-003
169
RX1
78La
bMD
em
ail r
e: D
aily
IT R
ound
s8/
14/2
007
FTC
-LA
BM
D-0
0317
1FT
C-L
AB
MD
-003
171
RX1
79La
bMD
em
ail r
e: D
aily
IT R
ound
s8/
16/2
007
FTC
-LA
BM
D-0
0317
2FT
C-L
AB
MD
-003
172
RX1
80La
bMD
em
ail r
e: D
aily
IT R
ound
s8/
17/2
007
FTC
-LA
BM
D-0
0317
3FT
C-L
AB
MD
-003
173
RX1
81La
bMD
em
ail r
e: D
aily
IT R
ound
s8/
21/2
007
FTC
-LA
BM
D-0
0317
4FT
C-L
AB
MD
-003
174
RX1
83La
bMD
em
ail r
e: D
aily
IT R
ound
s8/
23/2
007
FTC
-LA
BM
D-0
0317
6FT
C-L
AB
MD
-003
176
RX1
84La
bMD
em
ail r
e: D
aily
IT R
ound
s8/
24/2
007
FTC
-LA
BM
D-0
0317
7FT
C-L
AB
MD
-003
177
RX1
85La
bMD
em
ail r
e: D
aily
IT R
ound
s8/
27/2
007
FTC
-LA
BM
D-0
0317
8FT
C-L
AB
MD
-003
178
RX1
86La
bMD
em
ail r
e: D
aily
IT R
ound
s8/
28/2
007
FTC
-LA
BM
D-0
0317
9FT
C-L
AB
MD
-003
179
RX1
87La
bMD
em
ail r
e: D
aily
IT R
ound
s8/
30/2
007
FTC
-LA
BM
D-0
0318
0FT
C-L
AB
MD
-003
180
RX1
88La
bMD
em
ail r
e: D
aily
IT R
ound
s8/
30/2
007
FTC
-LA
BM
D-0
0318
1FT
C-L
AB
MD
-003
181
RX1
89La
bMD
em
ail r
e: D
aily
IT R
ound
s9/
11/2
007
FTC
-LA
BM
D-0
0318
3FT
C-L
AB
MD
-003
183
RX1
90La
bMD
em
ail r
e: D
aily
IT R
ound
s9/
12/2
007
FTC
-LA
BM
D-0
0318
4FT
C-L
AB
MD
-003
184
RX1
91La
bMD
em
ail r
e: D
aily
IT R
ound
s9/
13/2
007
FTC
-LA
BM
D-0
0318
5FT
C-L
AB
MD
-003
185
RX1
92La
bMD
em
ail r
e: D
aily
IT R
ound
s9/
14/2
007
FTC
-LA
BM
D-0
0318
6FT
C-L
AB
MD
-003
186
RX1
93La
bMD
em
ail r
e: D
aily
IT R
ound
s9/
17/2
007
FTC
-LA
BM
D-0
0318
7FT
C-L
AB
MD
-003
187
RX1
94La
bMD
em
ail r
e: D
aily
IT R
ound
s9/
18/2
007
FTC
-LA
BM
D-0
0318
8FT
C-L
AB
MD
-003
188
RX1
95La
bMd
Em
ail r
e: D
aily
IT R
ound
s9/
20/2
007
FTC
-LA
BM
D-0
0318
9FT
C-L
AB
MD
-003
189
RX1
96La
bMd
Em
ail r
e: D
aily
IT R
ound
s9/
26/2
007
FTC
-LA
BM
D-0
0319
0FT
C-L
AB
MD
-003
190
RX1
97La
bMd
Em
ail r
e: D
aily
IT R
ound
s9/
27/2
007
FTC
-LA
BM
D-0
0319
1FT
C-L
AB
MD
-003
191
RX1
98La
bMd
Em
ail r
e: D
aily
IT R
ound
s10
/2/2
007
FTC
-LA
BM
D-0
0319
3FT
C-L
AB
MD
-003
193
RX1
99La
bMd
Em
ail r
e: D
aily
IT R
ound
s10
/8/2
007
FTC
-LA
BM
D-0
0319
6FT
C-L
AB
MD
-003
196
RX2
00La
bMd
Em
ail r
e: D
aily
IT R
ound
s10
/11/
2007
FTC
-LA
BM
D-0
0319
7FT
C-L
AB
MD
-003
197
RX2
01La
bMd
Em
ail r
e: D
aily
IT R
ound
s10
/16/
2007
FTC
-LA
BM
D-0
0319
8FT
C-L
AB
MD
-003
198
RX2
02La
bMd
Em
ail r
e: D
aily
IT R
ound
s10
/19/
2007
FTC
-LA
BM
D-0
0319
9FT
C-L
AB
MD
-003
199
RX2
03La
bMd
Em
ail r
e: D
aily
IT R
ound
s10
/25/
2007
FTC
-LA
BM
D-0
0320
1FT
C-L
AB
MD
-003
201
RX2
04La
bMd
Em
ail r
e: D
aily
IT R
ound
s10
/28/
2007
FTC
-LA
BM
D-0
0320
2FT
C-L
AB
MD
-003
202
RX2
05La
bMd
Em
ail r
e: D
aily
IT R
ound
s10
/30/
2007
FTC
-LA
BM
D-0
0320
4FT
C-L
AB
MD
-003
204
RX2
06La
bMd
Em
ail r
e: D
aily
IT R
ound
s11
/5/2
007
FTC
-LA
BM
D-0
0320
7FT
C-L
AB
MD
-003
207
RX2
07La
bMd
Em
ail r
e: D
aily
IT R
ound
s11
/7/2
007
FTC
-LA
BM
D-0
0320
8FT
C-L
AB
MD
-003
208
RX2
08La
bMd
Em
ail r
e: D
aily
IT R
ound
s11
/9/2
007
FTC
-LA
BM
D-0
0320
9FT
C-L
AB
MD
-003
209
RX2
09La
bMd
Em
ail r
e: D
aily
IT R
ound
s11
/15/
2007
FTC
-LA
BM
D-0
0321
0FT
C-L
AB
MD
-003
210
RX2
10La
bMd
Em
ail r
e: D
aily
IT R
ound
s11
/19/
2007
FTC
-LA
BM
D-0
0321
1FT
C-L
AB
MD
-003
211
RX2
11La
bMd
Em
ail r
e: D
aily
IT R
ound
s11
/20/
2007
FTC
-LA
BM
D-0
0321
2FT
C-L
AB
MD
-003
212
FTC
Doc
ket N
o. 9
357
Pag
e 11
of 1
7JX
0002
pag
e 13
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#R
X213
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
11/2
3/20
07FT
C-L
AB
MD
-003
214
FTC
-LA
BM
D-0
0321
4R
X214
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
11/2
6/20
07FT
C-L
AB
MD
-003
215
FTC
-LA
BM
D-0
0321
5R
X215
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
11/3
0/20
07FT
C-L
AB
MD
-003
216
FTC
-LA
BM
D-0
0321
6R
X216
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
12/3
/200
7FT
C-L
AB
MD
-003
217
FTC
-LA
BM
D-0
0321
7R
X217
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
12/4
/200
7FT
C-L
AB
MD
-003
218
FTC
-LA
BM
D-0
0321
8R
X218
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
12/5
/200
7FT
C-L
AB
MD
-003
219
FTC
-LA
BM
D-0
0321
9R
X219
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
12/7
/200
7FT
C-L
AB
MD
-003
220
FTC
-LA
BM
D-0
0322
0R
X220
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
12/1
7/20
07FT
C-L
AB
MD
-003
221
FTC
-LA
BM
D-0
0322
1R
X221
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
12/2
0/20
07FT
C-L
AB
MD
-003
223
FTC
-LA
BM
D-0
0322
3R
X222
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
1/2/
2008
FTC
-LA
BM
D-0
0322
4FT
C-L
AB
MD
-003
224
RX2
23La
bMd
Em
ail r
e: D
aily
IT R
ound
s1/
3/20
08FT
C-L
AB
MD
-003
225
FTC
-LA
BM
D-0
0322
5R
X224
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
1/8/
2008
FTC
-LA
BM
D-0
0322
6FT
C-L
AB
MD
-003
226
RX2
25La
bMd
Em
ail r
e: D
aily
IT R
ound
s1/
9/20
08FT
C-L
AB
MD
-003
227
FTC
-LA
BM
D-0
0322
7R
X226
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
1/11
/200
8FT
C-L
AB
MD
-003
228
FTC
-LA
BM
D-0
0322
8R
X227
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
1/15
/200
8FT
C-L
AB
MD
-003
229
FTC
-LA
BM
D-0
0322
9R
X228
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
1/16
/200
8FT
C-L
AB
MD
-003
230
FTC
-LA
BM
D-0
0323
0R
X229
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
1/17
/200
8FT
C-L
AB
MD
-003
231
FTC
-LA
BM
D-0
0323
1R
X230
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
1/21
/200
8FT
C-L
AB
MD
-003
232
FTC
-LA
BM
D-0
0323
2R
X231
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
1/24
/200
8FT
C-L
AB
MD
-003
233
FTC
-LA
BM
D-0
0323
3R
X232
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
1/29
/200
8FT
C-L
AB
MD
-003
234
FTC
-LA
BM
D-0
0323
4R
X233
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
1/31
/200
8FT
C-L
AB
MD
-003
235
FTC
-LA
BM
D-0
0323
5R
X234
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
2/5/
2008
FTC
-LA
BM
D-0
0323
6FT
C-L
AB
MD
-003
236
RX2
35La
bMd
Em
ail r
e: D
aily
IT R
ound
s2/
6/20
08FT
C-L
AB
MD
-003
237
FTC
-LA
BM
D-0
0323
7R
X236
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
3/15
/200
8FT
C-L
AB
MD
-003
238
FTC
-LA
BM
D-0
0323
8R
X237
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
3/17
/200
8FT
C-L
AB
MD
-003
239
FTC
-LA
BM
D-0
0323
9R
X238
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
3/20
/200
8FT
C-L
AB
MD
-003
240
FTC
-LA
BM
D-0
0324
0R
X239
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
3/28
/200
8FT
C-L
AB
MD
-003
241
FTC
-LA
BM
D-0
0324
1R
X240
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
4/22
/200
8FT
C-L
AB
MD
-003
242
FTC
-LA
BM
D-0
0324
2R
X241
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
4/24
/200
8FT
C-L
AB
MD
-003
243
FTC
-LA
BM
D-0
0324
3R
X242
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
5/9/
2008
FTC
-LA
BM
D-0
0324
4FT
C-L
AB
MD
-003
244
RX2
43La
bMd
Em
ail r
e: D
aily
IT R
ound
s5/
27/2
008
FTC
-LA
BM
D-0
0324
5FT
C-L
AB
MD
-003
245
RX2
44La
bMd
Em
ail r
e: D
aily
IT R
ound
s5/
28/2
008
FTC
-LA
BM
D-0
0324
6FT
C-L
AB
MD
-003
246
RX2
45La
bMd
Em
ail r
e: D
aily
IT R
ound
s6/
2/20
08FT
C-L
AB
MD
-003
247
FTC
-LA
BM
D-0
0324
7R
X246
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
6/3/
2008
FTC
-LA
BM
D-0
0324
8FT
C-L
AB
MD
-003
248
RX2
47La
bMd
Em
ail r
e: D
aily
IT R
ound
s6/
4/20
08FT
C-L
AB
MD
-003
249
FTC
-LA
BM
D-0
0324
9R
X248
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
6/5/
2008
FTC
-LA
BM
D-0
0325
0FT
C-L
AB
MD
-003
250
FTC
Doc
ket N
o. 9
357
Pag
e 12
of 1
7JX
0002
pag
e 14
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#R
X249
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
6/6/
2008
FTC
-LA
BM
D-0
0325
1FT
C-L
AB
MD
-003
251
RX2
50La
bMd
Em
ail r
e: D
aily
IT R
ound
s6/
10/2
008
FTC
-LA
BM
D-0
0325
2FT
C-L
AB
MD
-003
252
RX2
51La
bMd
Em
ail r
e: D
aily
IT R
ound
s6/
11/2
008
FTC
-LA
BM
D-0
0325
3FT
C-L
AB
MD
-003
253
RX2
52La
bMd
Em
ail r
e: D
aily
IT R
ound
s6/
12/2
008
FTC
-LA
BM
D-0
0325
4FT
C-L
AB
MD
-003
254
RX2
53La
bMd
Em
ail r
e: D
aily
IT R
ound
s6/
17/2
008
FTC
-LA
BM
D-0
0325
5FT
C-L
AB
MD
-003
255
RX2
54La
bMd
Em
ail r
e: D
aily
IT R
ound
s7/
2/20
08FT
C-L
AB
MD
-003
256
FTC
-LA
BM
D-0
0325
6R
X255
LabM
d E
mai
l re:
Dai
ly IT
Rou
nds
7/3/
2008
FTC
-LA
BM
D-0
0325
7FT
C-L
AB
MD
-003
257
RX2
56La
bMd
Em
ail r
e: D
aily
IT R
ound
s7/
10/2
008
FTC
-LA
BM
D-0
0325
8FT
C-L
AB
MD
-003
258
RX2
57La
bMd
Em
ail r
e: D
aily
IT R
ound
s7/
14/2
008
FTC
-LA
BM
D-0
0325
9FT
C-L
AB
MD
-003
259
RX2
58La
bMd
Em
ail r
e: D
aily
IT R
ound
s7/
15/2
008
FTC
-LA
BM
D-0
0326
0FT
C-L
AB
MD
-003
260
RX2
59La
bMd
Em
ail r
e: D
aily
IT R
ound
s7/
16/2
008
FTC
-LA
BM
D-0
0326
1FT
C-L
AB
MD
-003
261
RX2
60La
bMd
Em
ail r
e: D
aily
IT R
ound
s7/
18/2
008
FTC
-LA
BM
D-0
0326
2FT
C-L
AB
MD
-003
262
RX2
61La
bMd
Em
ail r
e: D
aily
IT R
ound
s7/
22/2
008
FTC
-LA
BM
D-0
0326
3FT
C-L
AB
MD
-003
263
RX2
62La
bMd
Em
ail r
e: D
aily
IT R
ound
s7/
29/2
008
FTC
-LA
BM
D-0
0326
4FT
C-L
AB
MD
-003
264
RX2
63La
bMd
Em
ail r
e: D
aily
IT R
ound
s7/
30/2
008
FTC
-LA
BM
D-0
0326
5FT
C-L
AB
MD
-003
265
RX2
64La
bMd
Em
ail r
e: D
aily
IT R
ound
s7/
31/2
008
FTC
-LA
BM
D-0
0326
6FT
C-L
AB
MD
-003
266
RX2
75Tr
endM
icro
Dai
ly V
irus
Rep
ort -
Jul
y 20
107/
30/2
010
FTC
-LA
BM
D-0
0335
9FT
C-L
AB
MD
-003
363
RX2
76Tr
endM
icro
Dai
ly V
irus
Rep
ort -
Jul
y 20
107/
29/2
010
FTC
-LA
BM
D-0
0336
4FT
C-L
AB
MD
-003
368
RX2
77Tr
endM
icro
Dai
ly V
irus
Rep
ort -
Jul
y 20
107/
24/2
010
FTC
-LA
BM
D-0
0336
9FT
C-L
AB
MD
-003
373
RX2
78Tr
endM
icro
Dai
ly V
irus
Rep
ort -
Jul
y 20
107/
20/2
010
FTC
-LA
BM
D-0
0337
4FT
C-L
AB
MD
-003
378
RX2
79Tr
endM
icro
Dai
ly V
irus
Rep
ort -
Jul
y 20
107/
27/2
010
FTC
-LA
BM
D-0
0337
9FT
C-L
AB
MD
-003
383
RX2
80Tr
endM
icro
Dai
ly V
irus
Rep
ort -
Jul
y 20
107/
26/2
010
FTC
-LA
BM
D-0
0338
4FT
C-L
AB
MD
-003
388
RX2
81Tr
endM
icro
Dai
ly V
irus
Rep
ort -
Jul
y 20
107/
16/2
010
FTC
-LA
BM
D-0
0338
9FT
C-L
AB
MD
-003
393
RX2
82Tr
endM
icro
Dai
ly V
irus
Rep
ort -
Jul
y 20
107/
15/2
010
FTC
-LA
BM
D-0
0339
4FT
C-L
AB
MD
-003
398
RX2
83Tr
endM
icro
Dai
ly V
irus
Rep
ort -
Jul
y 20
107/
23/2
010
FTC
-LA
BM
D-0
0339
9FT
C-L
AB
MD
-003
403
RX2
85Tr
endM
icro
Dai
ly V
irus
Rep
ort -
Jul
y 20
107/
19/2
010
FTC
-LA
BM
D-0
0341
3FT
C-L
AB
MD
-003
417
FTC
Doc
ket N
o. 9
357
Pag
e 13
of 1
7JX
0002
pag
e 15
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#
RX2
86Tr
endM
icro
Dai
ly V
irus
Rep
ort -
Jul
y 20
107/
18/2
010
FTC
-LA
BM
D-0
0341
8FT
C-L
AB
MD
-003
422
RX2
87Tr
endM
icro
Dai
ly V
irus
Rep
ort -
Jul
y 20
107/
21/2
010
FTC
-LA
BM
D-0
0342
3FT
C-L
AB
MD
-003
427
RX2
89M
alw
are
Qui
cksc
an L
ogFT
C-L
AB
MD
-003
429
FTC
-LA
BM
D-0
0342
9R
X290
Mal
war
e Q
uick
scan
Log
FTC
-LA
BM
D-0
0343
0FT
C-L
AB
MD
-003
430
RX2
91M
alw
are
Qui
cksc
an L
ogFT
C-L
AB
MD
-003
431
FTC
-LA
BM
D-0
0343
1R
X292
Mal
war
e Q
uick
scan
Log
FTC
-LA
BM
D-0
0343
2FT
C-L
AB
MD
-003
432
RX2
93M
alw
are
Qui
cksc
an L
ogFT
C-L
AB
MD
-003
433
FTC
-LA
BM
D-0
0343
3R
X294
Mal
war
e Q
uick
scan
Log
FTC
-LA
BM
D-0
0343
4FT
C-L
AB
MD
-003
434
RX2
95M
alw
are
Qui
cksc
an L
ogFT
C-L
AB
MD
-003
435
FTC
-LA
BM
D-0
0343
5R
X296
Mal
war
e Q
uick
scan
Log
FTC
-LA
BM
D-0
0343
6FT
C-L
AB
MD
-003
436
RX2
97M
alw
are
Qui
cksc
an L
ogFT
C-L
AB
MD
-003
437
FTC
-LA
BM
D-0
0343
7R
X299
Mal
war
e Q
uick
scan
Log
7/1/
2010
FTC
-LA
BM
D-0
0343
9FT
C-L
AB
MD
-003
439
RX3
00M
alw
are
Qui
cksc
an L
og7/
5/20
10FT
C-L
AB
MD
-003
440
FTC
-LA
BM
D-0
0344
0R
X301
Mal
war
e Q
uick
scan
Log
7/22
/201
0FT
C-L
AB
MD
-003
441
FTC
-LA
BM
D-0
0344
1R
X302
Mal
war
e Q
uick
scan
Log
7/22
/201
0FT
C-L
AB
MD
-003
442
FTC
-LA
BM
D-0
0344
2R
X303
Mal
war
e Q
uick
scan
Log
7/25
/201
0FT
C-L
AB
MD
-003
443
FTC
-LA
BM
D-0
0344
3
RX3
05La
bMD
Em
ploy
ee S
epar
atio
n A
gree
men
t - P
atric
k H
owar
d7/
3/20
04FT
C-L
AB
MD
-003
461
FTC
-LA
BM
D-0
0347
0
RX3
11La
bMD
Em
ploy
ee H
andb
ook
ackn
owle
dgm
ent p
age-
Woo
dson
5/16
/200
7FT
C-L
AB
MD
-003
586
FTC
-LA
BM
D-0
0358
6
RX3
24La
bMD
Ser
verr
oom
viru
s sc
an -
July
20
10FT
C-L
AB
MD
-003
737
FTC
-LA
BM
D-0
0373
7
RX3
37Fo
rm L
ette
r fro
m L
abM
D to
affe
cted
pa
tient
s3/
27/2
013
FTC
-LA
BM
D-0
0391
3FT
C-L
AB
MD
-003
915
RX3
38H
andb
ook
Rec
eipt
Sig
ned
By
Adn
an S
aver
a 11
/9/2
007
FTC
-LA
BM
D-0
0409
8FT
C-L
AB
MD
-004
098
RX3
40
Em
ai F
rom
J. B
oyle
To
mik
elab
md@
gmai
l.com
; m
dort@
aol.c
om
9/27
/201
0FT
C-L
AB
MD
-004
305
FTC
-LA
BM
D-0
0430
9R
X341
Em
ail F
rom
G. S
chul
tz to
R. B
obac
k 5/
23/2
008
FTC
-LA
BM
D-0
0431
0FT
C-L
AB
MD
-004
313
RX3
42E
mai
l fro
m J
. Boy
le to
W. H
ardi
n re
: P
reve
ntat
ive
Mai
nten
ance
1/5/
2007
FTC
-LA
BM
D-0
0433
9FT
C-L
AB
MD
-004
339
RX3
43E
mai
l fro
m W
. Har
din
to J
. Boy
le re
: pr
even
tativ
e m
aint
enan
ce1/
5/20
07FT
C-L
AB
MD
-004
340
FTC
-LA
BM
D-0
0434
1
FTC
Doc
ket N
o. 9
357
Pag
e 14
of 1
7JX
0002
pag
e 16
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#
RX3
47E
mai
l fro
m K
. Jes
tes
to M
. Woo
d re
: R
edac
tedL
abM
dsLe
tter
4/8/
2013
FTC
-SA
C-0
0110
8FT
C-S
AC
-001
108
RX3
48La
bMD
Pat
ient
Not
ifica
tion
Lette
r [re
dact
ed]
3/27
/201
3FT
C-S
AC
-001
109
FTC
-SA
C-0
0111
0
RX3
49
Em
ail f
rom
A. S
heer
to K
. Jes
tes
re:
Hi K
arin
a - T
he p
acka
ge a
rriv
ed
safe
and
sou
nd. A
lain
.10
/31/
2012
FTC
-SA
C-0
0113
0FT
C-S
AC
-001
130
RX3
50E
mai
l fro
m K
. Jes
tes
to A
. She
er re
: La
bMD
4/7/
2013
FTC
-SA
C-0
0113
4FT
C-S
AC
-001
134
RX3
51E
mai
l fro
m A
. She
er to
K. J
este
s re
: La
bMD
from
Sac
ram
eno
Pol
ice
10/9
/201
2FT
C-S
AC
-001
142
FTC
-SA
C-0
0114
2
RX3
52E
mai
l fro
m R
. Yod
aike
n to
K. J
este
s re
: Lab
MD
10/1
1/20
12FT
C-S
AC
-001
143
FTC
-SA
C-0
0114
3
RX3
53E
mai
l fro
m R
. Yod
aike
n to
K. J
este
s re
: my
first
pho
ne c
all
4/4/
2013
FTC
-SA
C-0
0114
6FT
C-S
AC
-001
146
RX3
54E
mai
l fro
m A
. She
er to
K. J
este
s re
: m
y fir
st p
hone
cal
l4/
4/20
13FT
C-S
AC
-001
148
FTC
-SA
C-0
0114
8
RX3
63E
mai
l fro
m J
. Boy
le to
M. D
augh
erty
re
: You
r Pas
swor
ds12
/16/
2010
FTC
-LA
BM
D-0
0439
6FT
C-L
AB
MD
-004
400
RX3
64J.
Boy
le e
mai
l to
M. D
augh
erty
re:
Hye
r Sof
twar
e re
ques
t11
/11/
2010
FTC
-LA
BM
D-0
0440
1FT
C-L
AB
MD
-004
401
RX4
05La
bMD
Thr
eat S
can
9/3/
2010
FTC
-LA
BM
D-0
0522
2FT
C-L
AB
MD
-005
248
RX4
06La
bMD
Thr
eat S
can
9/3/
2010
FTC
-LA
BM
D-0
0624
6FT
C-L
AB
MD
-006
270
RX4
07La
bMD
Thr
eat S
can
9/3/
2010
FTC
-LA
BM
D-0
0644
8FT
C-L
AB
MD
-006
471
RX4
08La
bMD
Thr
eat S
can
9/3/
2010
FTC
-LA
BM
D-0
0647
2FT
C-L
AB
MD
-006
495
RX4
09La
bMD
Thr
eat S
can
9/3/
2010
FTC
-LA
BM
D-0
0649
6FT
C-L
AB
MD
-006
519
RX4
10La
bMD
Thr
eat S
can
9/3/
2010
FTC
-LA
BM
D-0
0652
0FT
C-L
AB
MD
-006
544
RX4
11C
omm
unic
atio
ns b
etw
een
J.P
arr
and
Tren
dMic
ro re
:ser
vice
12/5
/201
1FT
C-T
RM
-000
574
FTC
-TR
M-0
0059
8R
X413
Ver
itas
Ser
ver B
acku
p R
epor
t7/
15/2
010
FTC
-LA
BM
D-0
1603
2FT
C-L
AB
MD
-016
038
RX4
15K
alou
stia
n ba
ckgr
ound
che
ck/A
. S
imm
ons'
resi
gnat
ion
FTC
-LA
BM
D-0
1618
0FT
C-L
AB
MD
-016
181
RX4
16L.
Hud
son
Term
inat
ion
Not
ice
6/28
/200
7FT
C-L
AB
MD
-016
182
FTC
-LA
BM
D-0
1618
3
RX4
21E
mai
l: K
. Jes
tes
to D
. Oje
da,
Sub
ject
: 10
/15/
2012
FTC
-SA
C-0
0110
5FT
C-S
AC
-001
105
FTC
Doc
ket N
o. 9
357
Pag
e 15
of 1
7JX
0002
pag
e 17
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#
RX4
22E
mai
l: K
. Jes
tes
to A
. She
er a
nd R
. Yo
daik
en, S
ubje
ct: E
rick
Gar
cia
3/11
/201
3FT
C-S
AC
-001
106
FTC
-SA
C-0
0110
6
RX4
24E
mai
l: K
. Jes
tes
to M
. Woo
d,
Sub
ject
: La
bMD
4/8/
2013
FTC
-SA
C-0
0110
8FT
C-S
AC
-001
108
RX4
29
Em
ail:
A. S
heer
to K
. Jes
tes,
S
ubje
ct:
LabM
D (A
ttach
: re
dact
ed
LabM
Ds
Lette
r(3.
27.2
3).p
df)
4/2/
2013
FTC
-SA
C-0
0111
5FT
C-S
AC
-001
115
RX4
33E
mai
l: A
. She
er to
K. J
este
s,
Sub
ject
: La
bMD
10/1
0/20
12FT
C-S
AC
-001
120
FTC
-SA
C-0
0112
0
RX4
35
Em
ail:
K. J
este
s to
A. S
heer
and
R.
Yoda
iken
, Sub
ject
: my
first
pho
ne
call
4/4/
2013
FTC
-SA
C-0
0112
2FT
C-S
AC
-001
122
RX4
41E
mai
l: A
. She
er to
K. J
este
s,
Sub
ject
: E
rick
Gar
cia
3/11
/201
3FT
C-S
AC
-001
128
FTC
-SA
C-0
0112
8
RX4
43
Em
ail:
A. S
heer
to K
. Jes
tes,
S
ubje
ct:
Hi K
arin
a. T
he p
acka
ge
arriv
ed s
afe
and
soun
d - t
hank
s.
Ala
in10
/31/
2013
FTC
-SA
C-0
0113
0FT
C-S
AC
-001
130
RX4
47E
mai
l: K
. Jes
tes
to A
. She
er,
Sub
ject
: Lab
MD
4/2/
2013
FTC
-SA
C-0
0113
4FT
C-S
AC
-001
134
RX4
48E
mai
l: A
. She
er to
K. J
este
s,
Sub
ject
: La
bMD
4/2/
2013
FTC
-SA
C-0
0113
5FT
C-S
AC
-001
135
RX4
49E
mai
l: A
. She
er to
K. J
este
s,
Sub
ject
: La
bMD
4/2/
2013
FTC
-SA
C-0
0113
6FT
C-S
AC
-001
136
RX4
50E
mai
l: A
. She
er to
K. J
este
s,
Sub
ject
: La
bMD
4/3/
2013
FTC
-SA
C-0
0113
7FT
C-S
AC
-001
137
RX4
51E
mai
l: A
. She
er to
K. J
este
s,
Sub
ject
: La
bMD
4/3/
2013
FTC
-SA
C-0
0113
8FT
C-S
AC
-001
138
RX4
52E
mai
l: A
. She
er to
K. J
este
s,
Sub
ject
: La
bMD
10/1
1/20
12FT
C-S
AC
-001
139
FTC
-SA
C-0
0113
9
RX4
54
Em
ail:
A. S
heer
to K
. Jes
tes,
S
ubje
ct:
LabM
D fr
om S
acra
men
to
Pol
ice
10/9
/201
2FT
C-S
AC
-001
141
FTC
-SA
C-0
0114
1
RX4
55
Em
ail:
A. S
heer
to K
. Jes
tes,
S
ubje
ct:
LabM
D fr
om S
acra
men
to
Pol
ice
10/9
/201
2FT
C-S
AC
-001
142
FTC
-SA
C-0
0114
2
FTC
Doc
ket N
o. 9
357
Pag
e 16
of 1
7JX
0002
pag
e 18
Join
t Stip
ulat
ions
on
Adm
issi
bilit
y of
Exh
ibits
: Atta
chm
ent A
Join
t Exh
ibits
Exhi
bit
No.
Res
pond
ent's
Exh
ibit
Des
crip
tion
Com
plai
nt C
ouns
el's
Exh
ibit
Des
crip
tion
Dat
eB
eg. B
ates
#En
d B
ates
#
RX4
56E
mai
l: R
. Yod
aike
n to
K. J
este
s,
Sub
ject
: Lab
MD
10/1
1/20
12FT
C-S
AC
-001
143
FTC
-SA
C-0
0114
3
RX4
59E
mai
l: R
. Yod
aike
n to
K. J
este
s,
Sub
ject
: m
y fir
st p
hone
cal
l4/
4/20
13FT
C-S
AC
-001
146
FTC
-SA
C-0
0114
6
RX4
60E
mai
l: A
. She
er to
K. J
este
s,
Sub
ject
: m
y fir
st p
hone
cal
l4/
5/20
13FT
C-S
AC
-001
147
FTC
-SA
C-0
0114
7
RX4
61E
mai
l: A
. She
er to
K. J
este
s,
Sub
ject
: m
y fir
st p
hone
cal
l4/
4/20
13FT
C-S
AC
-001
148
FTC
-SA
C-0
0114
8
RX4
63E
mai
l: A
. She
er to
K. J
este
s,
Sub
ject
: re
leas
e of
evi
denc
e10
/15/
2012
FTC
-SA
C-0
0115
1FT
C-S
AC
-001
151
RX4
64E
mai
l: A
. She
er to
K. J
este
s,
Sub
ject
: re
leas
e of
evi
denc
e10
/18/
2012
FTC
-SA
C-0
0115
2FT
C-S
AC
-001
152
RX4
65
Em
ail:
R. Y
odai
ken
to A
. She
er a
nd
K. J
este
s, S
ubje
ct: r
elea
se o
f ev
iden
ce10
/18/
2012
FTC
-SA
C-0
0115
3FT
C-S
AC
-001
153
RX4
67E
mai
l: A
. She
er to
K. J
este
s,
Sub
ject
: re
leas
e of
evi
denc
e10
/15/
2012
FTC
-SA
C-0
0115
6FT
C-S
AC
-001
156
RX4
68E
mai
l: R
. Yod
aike
n to
K. J
este
s,
Sub
ject
: Sac
Cou
nty
Cou
rts o
nlin
e4/
11/2
013
FTC
-SA
C-0
0115
7FT
C-S
AC
-001
157
RX4
72E
mai
l: R
. Yod
aike
n to
K. J
este
s,
Sub
ject
: Upd
ate
2/14
/201
3FT
C-S
AC
-001
161
FTC
-SA
C-0
0116
1
RX4
73E
mai
l: K
. Jes
tes
to R
. Yod
aike
n,
Sub
ject
: rel
ease
of e
vide
nce
10/1
5/20
12FT
C-S
AC
-001
162
FTC
-SA
C-0
0116
2
RX4
80E
mai
l: K
. Jes
tes
to A
. She
er a
nd R
. Yo
daik
en, S
ubje
ct: U
pdat
e2/
14/2
013
FTC
-SA
C-0
0116
9FT
C-S
AC
-001
169
RX5
18C
ompl
aint
Cou
nsel
's R
espo
nses
to
LabM
D's
Firs
t Set
of I
nter
roga
torie
s3/
26/2
014
RX5
26
Com
plai
nt C
ouns
el's
Am
ende
d R
espo
nse
to L
abM
D, I
nc.'s
Firs
t Set
of
Req
uest
s fo
r Adm
issi
ont
4/1/
2014
FTC
Doc
ket N
o. 9
357
Pag
e 17
of 1
7JX
0002
pag
e 19
PUBLIC
CERTIFICATE OF SERVICE
I hereby certify that on May 14, 2014, I filed the foregoing document electronically through the Office of the Secretary’s FTC E-filing system, which will send notification of such filing to:
Donald S. Clark Secretary Federal Trade Commission
600 Pennsylvania Avenue, NW, Room H-113 Washington, DC 20580
I also certify that I caused a copy of the foregoing document to be delivered via electronic mail and by hand to:
The Honorable D. Michael Chappell Chief Administrative Law Judge Federal Trade Commission 600 Pennsylvania Avenue, NW, Room H-110 Washington, DC 20580
I further certify that I caused a copy of the foregoing document to be served via electronic mail to:
Michael Pepson Lorinda Harris Hallee Morgan Robyn Burrows Kent Huntington Daniel Epstein Patrick Massari Cause of Action 1919 Pennsylvania Avenue, NW, Suite 650 Washington, DC 20006 [email protected] [email protected]@[email protected]@[email protected]@causeofaction.org
Reed Rubinstein William A. Sherman, II Sunni Harris Dinsmore & Shohl, LLP
JX0002 page 20
JX0002 page 21